Clinical Trial Information
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecaptagene Vicleucel CAR-T in Multiple Myeloma Patients
- Protocol Number: A062102
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Secondary Protocol No.: A062102
- Phase: II
- NCT ID: NCT06179888
Scope Information
- Scope:
- National
- Disease Site(s):
- Multiple Myeloma
